product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
PKA RI-α (D54D9) Rabbit mAb
catalog :
5675
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
D54D9
reactivity :
human, mouse, rat
application :
western blot, immunoprecipitation, other
citations: 3
Published Application/Species/Sample/DilutionReference
  • other; human; loading ...; fig 4c
Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  • western blot; human; fig 3
Riggle K, Riehle K, Kenerson H, Turnham R, Homma M, Kazami M, et al. Enhanced cAMP-stimulated protein kinase A activity in human fibrolamellar hepatocellular carcinoma. Pediatr Res. 2016;80:110-8 pubmed publisher
  • western blot; mouse; 1:1000; fig 4e
Rajan S, Dickson L, Mathew E, Orr C, Ellenbroek J, Philipson L, et al. Chronic hyperglycemia downregulates GLP-1 receptor signaling in pancreatic β-cells via protein kinase A. Mol Metab. 2015;4:265-76 pubmed publisher
product information
SKU :
5675S
Product-Name :
PKA RI-α (D54D9) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R, Hm, Mk
Applications :
Immunoprecipitation
Product-Category :
Ca, cAMP and Lipid Signaling
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
48
Host :
Rabbit
Target :
PRKAR1A
Primary-Protein :
PKAR1A
Alt-Names :
CAR,CNC,CNC1,DKFZp779L0468,KAP0,MGC17251,PKR1,PPNAD1,PRKAR1,PRKAR1A,TSE1,Tissue-specific extinguisher 1,cAMP-dependent protein kinase regulatory subunit RIalpha,cAMP-dependent protein kinase type I-alpha regulatory chain,cAMP-dependent protein kinase type I-alpha regulatory subunit,protein kinase A type 1a regulatory subunit,protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.